- $2.11bn
- $2.01bn
- $2.07bn
- 96
- 77
- 89
- 99
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,373 | 1,588 | 1,568 | 1,821 | 2,068 |
Cost of Revenue | |||||
Gross Profit | 330 | 391 | 394 | 461 | 518 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 1,293 | 1,493 | 1,462 | 1,674 | 1,902 |
Operating Profit | 79.5 | 95.3 | 106 | 147 | 166 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 86.2 | 96 | 107 | 147 | 163 |
Provision for Income Taxes | |||||
Net Income After Taxes | 63.2 | 69.1 | 74.4 | 106 | 119 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 63.2 | 69.1 | 74.4 | 106 | 119 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 63.2 | 69.1 | 74.4 | 106 | 119 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.233 | 0.262 | 0.278 | 3.93 | 4.48 |